Gloria Chung
Optometrist · Whitestone, NYNPI 1184853772
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.6% of the total across 214 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,298 and has fallen 88.7% since, to $147 in 2025. Among optometrist clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 214 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$965
- AbbVie$873
- Oyster Point Pharma, Inc.$567
- Novartis$493
- Mallinckrodt Hospital Products Inc.$367
- Bausch & Lomb Americas Inc.$180
- plus $659 from 11 others
What the payments were for
- Food & beverage$4,00798%
- Education$982%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 63 | $965 |
| AbbVie(2 entities) | 60 | $873 |
| Oyster Point Pharma, Inc. | 23 | $567 |
| Novartis | 32 | $493 |
| Mallinckrodt Hospital Products Inc. | 8 | $367 |
| Bausch & Lomb Americas Inc. | 4 | $180 |
| NEW World Medical,inc. | 1 | $162 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 5 | $90 |
| Kala Pharmaceuticals, Inc. | 3 | $70 |
| Aerie Pharmaceuticals, Inc. | 4 | $70 |
| Alcon | 3 | $64 |
| Rxsight Inc | 1 | $48 |
| Eyevance Pharmaceuticals LLC | 2 | $41 |
| Johnson & Johnson Vision Care, Inc. | 1 | $41 |
| Sight Sciences, Inc. | 2 | $27 |
| Thea Pharma Inc. | 1 | $26 |
| Shire North American Group Inc | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kahook Dual Blade$162
- Streamline Surgical System$162
- Ahmed Glaucoma Valve$162
- CEQUA$150
- ACTHAR$147
- MIEBO$125
- XIIDRA$125
How this compares
$4,105 in reported general payments places this provider in the 90th percentile of 2,743 optometrist providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 356 | $371,836 |
| XiidraLifitegrast | 77 | $93,384 |
| LumiganBimatoprost | 139 | $73,182 |
| CequaCyclosporine | 31 | $28,058 |
| CombiganBrimonidine Tartrate/Timolol | 24 | $11,979 |
| Alphagan PBrimonidine Tartrate | 23 | $11,267 |
| RhopressaNetarsudil Mesylate | 22 | $10,621 |
| Cyclosporine | 19 | $8,760 |
| Brimonidine Tartrate | 46 | $8,390 |
| Latanoprost | 263 | $2,884 |
| Timolol Maleate | 79 | $1,805 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 42 | $517 |
| Dorzolamide Hcl | 12 | $363 |
| Azelastine Hcl | 13 | $283 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis, Lumigan, Combigan, Alphagan P | $873 | $468,264542 claims |
| Bausch & Lomb Americas Inc.Xiidra | $180 | $93,38477 claims |
| Sun Pharmaceutical Industries Inc.Cequa | $965 | $28,05831 claims |
| Aerie Pharmaceuticals, Inc.Rhopressa | $70 | $10,62122 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,743 optometrist providers in New York.
Other optometrist in Whitestone
- Roy KlineLake Katrine$822K
- Susan ResnickNew York$463K
- Murray FingeretHewlett$374K
- Albert MorierSlingerlands$347K
- Denise WhittamNew York$343K
- Justin BazanBrooklyn$303K
- Jennifer TsaiNew York$275K
- Alexander KabiriQueens Village$268K
- Sophia VisanjiNew York$233K
- Jason ComptonNew York$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.